Table 1. Characteristics of the individual studies.
| Accession number | Subject | Race | Sample size(High: LowBMD) | Outlier removed(High: LowBMD) | Platform | Tissue/cell | Samplesource |
|---|---|---|---|---|---|---|---|
| GSE56815 | Pre- and postmenopausal female | Caucasian | 80(40:40) | 3(2:1) | GPL96 HG-U133A | Peripheral blood monocytes | in vivo |
| GSE7158 | Premenopausal female | Chinese | 26(14:12) | 2(2:0) | GPL570 HG-U133_Plus_2 | Peripheral blood monocytes | in vivo |
| GSE2208 | Pre- and postmenopausal female | Caucasian | 19(10:9) | 0(0:0) | GPL96 HG-U133A | Peripheral blood monocytes | in vivo |
| E-MEXP-1618 | Postmenopausal female | Caucasian | 84(45:39) | 4(1:3) | GPL570 HG-U133_Plus_2 | Bone biopsies | in vivo |
| GSE7429 | Postmenopausal female | Caucasian | 20(10:10) | 3(2:1) | GPL96 HG-U133A | Circulating B cells | in vivo |
| GSE13850 | Postmenopausal female | Caucasian | 20(10:10) | 1(0:1) | GPL96 HG-U133A | Circulating B cells | in vivo |
Note: HG-U133_Plus_2: Affymetrix Human Genome U133 Plus 2.0 Array
HG-U133A: Affymetrix Human Genome U133A Array